Latest News Read the latest updates from Quotient Sciences. Contact Us Home News News & Announcements Quotient Sciences and Vasa Therapeutics Announce Dosing of First Subjects with VS-041, a Novel Heart Failure Treatment Read More Categories View all categoriesAcquisitions & GrowthADMEAlnwickArticles & Publicationsartificial intelligenceAwards & RecognitionBioanalysisClinical TrialsCustomer MilestoneCustomer PartnershipDr. Andy LewisDr. Asma PatelDr. Dolly JacobDr. Gareth JenkinsDr. Helen BakerDr. Paul QuigleyDr. Stuart McDougallDr. Vanessa ZannEleanor RowEventsInnovationInterviewsJohn McDermottNazim KanjiNews & AnnouncementsNottingham, UKPhiladelphia, PAReading, UKRegulatory TrendsSynthesis-to-ClinicThierry Van NieuwenhoveTranslational Pharmaceutics® Publish Date View all time20242023202220212020201920182017 Fulltext search 1 - 5 of 129 results Pagination Page 1 Page 2 Page 3 Page 4 Page 5 … Next page Next › Last page Last » Learn more about Quotient Sciences At a Glance We are a drug development and manufacturing accelerator for the global pharmaceutical industry. Learn More Our Locations Access directions and information about our facilities in the US & UK. Browse Locations Careers See what life is like at Quotient Sciences and how you can join our global team. Browse Jobs Ready to get started? Schedule a meeting with us at an upcoming industry event. Contact Us See Events